ABSTRACT The mob as tumor suppressor (mats) family genes are highly conserved in evolution. The Drosophila mats gene functions in the Hippo signaling pathway to control tissue growth by regulating cell proliferation and apoptosis. However, nothing is known about whether mats family genes are required for the normal development of vertebrates. Here we report that zebrafish has three mats family genes. Expression of mats1 is maternally activated and continues during embryogenesis. Through a morpholino-based knockdown approach, we found that mats1 is required for normal embryonic development. Reduction of mats1 function caused developmental delay, a phenotype similar to that of Drosophila mats homozygous mutants. Both cell proliferation and apoptosis were defective in mats1 morphant embryos. Moreover, mats1 morphant cells exhibited a growth advantage in chimeric embryos, similar to mats mutant cells in mosaic tissues in Drosophila. Therefore mats1 plays a critical role in regulating cell proliferation and apoptosis during early development in zebrafish, and the role of mats family genes in growth regulation is conserved in both invertebrates and vertebrates. This work shows that zebrafish can be a good model organism for further analysis of Hippo signaling pathway.
Introduction
Hippo (Hpo) signaling plays a crucial role in controlling cell proliferation and apoptosis, and disruption of this growth regulatory mechanism causes tissue overgrowth in Drosophila (reviewed in Hariharan and Bilder, 2006; Harvey and Tapon, 2007; Pan, 2007; Saucedo and Edgar, 2007) . While Hpo signaling is mediated through several tumor suppressor proteins such as Hippo (Hpo) protein kinase to activate Warts (Wts)/Large tumor suppressor (Lats) protein kinase, a Mob family protein Mats (Mob as tumor suppressor) is critical for activating the catalytic activity of Wts kinase (Lai et al., 2005; Wei et al., 2007) . Consequently, a growth-promoting transcription coactivator Yorkie (Yki) and the Drosophila ortholog of mammalian Yes-associated protein (YAP) are inhibited by Wts/Lats protein kinases via phosphorylation and cytoplasmic retention (Huang et al., 2005; Dong et al., 2007; Wei et al., 2007; Zhao et al., 2007; Hao et al., 2008) . When Yki is present in the nucleus, the TEAD family transcription factor Scalloped (Sd) is turned on to promote tissue growth by forming a complex with Yki to directly activate transcription of target genes such as the Drosophila inhibitor of apoptosis (diap1) gene (Wu et al., 2008; Zhang et al., 2008) . Although the Hpo signaling pathway has been extensively studied in Drosophila, much less is known about its components and physiological function in vertebrates.
The first Mob family protein was discovered in yeast as "Mps one binder protein" and shown to be a binding partner as well as a coactivator of protein kinases of the Ndr (nuclear Dbf2-related) family in regulating mitotic exit and cytokinesis (reviewed in Hergovich et al., 2006b) . Mob proteins also have been studied in fly and mammalian cells in recent years. In Drosophila, Mats (also called dMob1) was discovered in 2005 as a coactivator of an Ndr family serine/threonine protein kinase Wts to control cell proliferation and apoptosis (Justice et al., 1995; Xu et al., 1995; Lai et al., 2005) . Recently, Mats has been shown to be phosphorylated and activated by Hpo/Mst protein kinases in both fly and human cells Praskova et al., 2008) . Interestingly, while loss of mats function causes tissue overgrowth in mosaic flies (Lai et al., 2005) , mutants homozygous for mats are developmentally delayed and die at an early larval stage (He et al., 2005; Shimizu et al., 2008) . Drosophila Mob family proteins also genetically interact with tricornered (trc), which is another Ndr family protein kinase in Drosophila and is required for the normal morphogenesis of a variety of polarized outgrowths (He et al., 2005) . In human, LATS1 interacts with MATS/MOBKL1, and hLATS1 activation may be mediated through rapid recruitment to the plasma membrane by hMATS (Hergovich et al., 2005; Hergovich et al., 2006a) . Functionally, hLATS1/hMATS complex appears to be required for cytokinesis and mitotic exit (Yang et al., 2004; Bothos et al., 2005) . Although a human mats ortholog hMATS1 can rescue the lethality and tumor phenotypes of Drosophila mats mutants (Lai et al., 2005) , nothing is known about the physiological function of mats family genes during vertebrates development.
We chose zebrafish to investigate the role of mats in vertebrate development, since zebrafish provides a genetic model system to study early development and cancer-related genes (Amaruda et al., 2002; Stern et al., 2003; Berghmans et al., 2005; Shepard et al., 2005) . Two mats orthologs have been identified in zebrafish (Lai et al., 2005) . Here, we report that the zebrafish genome has one more mats ortholog. We show that zebrafish mats1 is maternally expressed and is also expressed throughout embryogenesis. Using a morpholino-based gene knockdown approach, we found that mats1 is required for normal embryonic development, and is involved in regulating both cell proliferation and apoptosis. Similar to what was observed in Drosophila, mats1 morphant cells seem to have a growth advantage over wild-type cells in chimeric zebrafish embryos. Our results suggest that growth regulatory properties of mats are conserved in vertebrates.
Results

Three mats orthologs exist in zebrafish
Through a phylogenetic analysis, two orthologs of the Drosophila mats gene have been identified in vertebrates (Lai et al., 2005) . In zebrafish, mats1 (also named mobkl1b for Mps One Binder kinase activator-like 1b) and mats2 (also named mobkl1a for Mps One Binder kinase activator-like 1a) genes encode protein products that share 85 and 88% identity with the Drosophila Mats protein, respectively (Lai et al., 2005; Supplementary Fig. S1A ). Through synteny analysis, the arrangement of genes in the flanking regions of mats1 and mats2 was found to be highly conserved in zebrafish, mouse and human (Supplementary Fig. S1B and S1C). These results confirmed the orthologous relationships of mats1 and mats2 genes in these vertebrates. By searching the updated zebrafish genome database, we found that zebrafish has an additional mats ortholog, mats3 (also named mob4b), whose intron-exon structure is identical to other vertebrate mats genes while other mob family genes have distinct intron-exon structures (X. Ye and Z.-C. Lai, unpublished results) . Similar to Mats1 and Mats2, the zebrafish Mats3 protein is 88% identical to Drosophila Mats. As mats3 is not found in other vertebrates, it is likely a product of gene duplications occurred after divergence of fish from other vertebrates. For clarity, the terms mats1, mats2 and mats3 refer to the above genes are used throughout this paper. In this study we have focused on mats1 to investigate its developmental role in zebrafish embryos.
mats1 mRNA is maternally stored and expressed during early embryonic development
To facilitate functional analysis of mats genes, expression of mats1 during early development was examined through RT-PCR and in situ hybridization. RT-PCR results showed that mats1 mRNA was detected at the one-cell stage of embryonic development ( Figure 1A ). Thus, mats1 mRNA is maternally provided. Moreover, mats1 was continuously expressed throughout the first three days after fertilization, with some reduction at 6 hours post fertilization (hpf) ( Figure 1A ). RNA whole-mount in situ hybridization confirmed this result, and provided information about the spatial distribution of mats1 mRNA ( Figure 1B) . Before 24 hpf, mats1 was broadly expressed in the embryo ( Figure 1B, a-g ). After 24 hpf, expression of mats1 was stronger in the head than in the trunk (Figure 1B, . This expression Anterior is towards the top and dorsal is towards right in (e). Anterior is towards left and dorsal towards top in (f-k). They are all showed by lateral view. Before 24 hpf, expression of mats1 is ubiquitous. After 24hpf, mats1 expression was observed in the head region of the body.
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Mats1 is required for normal zebrafish development 527 analysis suggests that mats1 plays a role during embryonic development.
mats1 is required for normal embryonic development
Morpholino-based antisense oligonucleotides provide an efficient and specific means to block protein translation in zebrafish embryos (Nasevicius and Ekker, 2000; Draper et al., 2001) . To investigate the function of mats1 during embryogenesis, a translation-blocking morpholino (MO1) and a splice-blocking morpholino (MO2) were designed to knock down mats1 expression (Figure 2A ). Interestingly, both MO1 and MO2 caused a phenotype with developmental delay. MO1 was less effective since only 20-30% of morphant embryos exhibited the delay phenotype. In contrast, MO2 was much more effective; over 70% of the morphant embryos showed the delay phenotype when injected with 8.5 ng of mats1 MO2. Among these abnormal mats1 morphants, over 50% of them showed 16.5 hpf morphology, 20-30% with morphology between 16 and 18 hpf stages, and 10-20% with morphology between 18 and 20 hpf stages. This effect was concentrationdependent (data not shown). Consequently, mats1 MO2 was used throughout this study.
To determine the efficiency and specificity of mats1 morpholino treatment, RT-PCR was done at both 10 hpf and 24 hpf with primers corresponding to exons flanking the MO2 target site (Figure 2A ). We found that MO2 treatment caused 70-80% reduction of-mats1 expression in embryos showing severe developmental delay (Figure 2A, lanes 4 and 8) , whereas normallooking morphant embryos had less reduction of mats1 expression (40-50% of the wild-type level) (Figure 2A, lanes 3 and 7) . While MO2 binding appears to block correct splicing of mats1 transcript, no aberrant splicing was observed. It is possible that the splice-modified mats1 mRNA cannot be exported and consequently degraded in the nucleus. As internal controls, expression of the two other mats orthologs mats2 and mats3 was not affected Rescue of mats1 morphants by mats1 mRNA is dosage-dependent. At 24 hpf, only 19% (n=181) of the mats1 MO2 morphant embryos were normal. However, co-injection of 300 pg mats1 mRNA with mats1 MO2 made 37% (n=142) of the embryos to become normal. When 600 pg mats1 mRNA was coinjected, 55% (n=196) of the embryos showed a normal phenotype. Although many remaining embryos still exhibited a developmental delay phenotype, the severity was decreased. Embryos injected with 8.5 ng MO Ctl were used as a control (n=134). All the statistical data included dead embryos. All the living embryos injected with 8.5 ng MO Ctl were normal. Standard errors were shown by the error bars.
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A by mats1 MO2 (Figure 2A ). These results indicated that mats1 mRNA levels can be effectively and specifically reduced by morpholino treatment. Moreover, mats1 mRNA was co-injected with mats1 MO2 to test whether mats1 mRNA is able to rescue the abnormal phenotypes induced by mats1 MO2. While injection of mats1 mRNA alone did not cause any abnormal phenotype ( Figure 2B -b), coinjection of mats1 mRNA with MO2 effectively rescued MO2 morphant embryos ( Figure 2B , compare image (d) with (c)). With 300 or 600 pg mats1 mRNA co-injection, normal-looking embryos increased from 19% to 36% and 55%, respectively ( Figure 2C ). Since 11 nucleotides which can be recognized by mats1 MO2 still Lateral view in (A-C'). Ventral view in (A"-C"). "Severe" represents mats1 MO2 morphants which showed severe developmental delay, while "mild" represents those showed a weaker developmental delay phenotype. At 24 hpf, some neurons in trunk (indicate by long arrow) had already emerged in wild-type embryos, but they were not observed in mats1 MO2 morphants. Eyes (indicated by short arrow) were either not visible (B'') or less developed (C'') in mats1 MO2 morphants. Similarly, the brain (indicate by arrow head) was less developed in mats1 MO2 morphants (B'',C''). (D-F') Embryos at 3.5 hpf. mats1 MO2 morphants show developmental delay at very early stage. Lateral view with anterior towards left in (D-F). Top view to see animal pole in (D'-F'). mats1 MO2 morphant embryos had fewer but bigger cells (F,F') compared to wild-type embryos (D,D') and embryos injected with MO Ctl (E,E'), suggesting that mats1 MO2 morphant cells divided less than control cells during the same period of time.
remained in the in vitro transcript mats1 mRNA, titration of mats1 MO2 by mats1 mRNA might exist. To further confirmed that the developmental delay phenotype was specifically caused by mats1 knock down, a putative mats1 MO2-binding defective (MO2-bd in short) mRNA in which 5 nucleotides in the mats1 MO2 binding region were mutated based on degeneracy of codons was also synthesized to do rescue experiment. With 20 pg MO2-bd mRNA co-injection, proportion of normal-looking embryos increased from 19 to 65% (Supplementary Figure S2 compare A with C). Consistently, while injected with 20 pg MO2-bd mRNA alone, no abnormal phenotype was observed (Supplementary Figure S2B) . It seemed that the putative MO2-bd mRNA can rescue the MO2 morphant embryos much more effectively than wild type mats1 mRNA. One explanation is that wild type mats1 but not the mutant mats1 mRNA can be targeted by MO2. These results support the idea that MO2-induced abnormalities were due to the reduction of mats1 function.
Some morpholinos are known to activate the p53 pathway by an off-target effect (Robu et al., 2007) . As mats1 morphant embryos exhibited elevated expression of ∆113p53 (a truncated version of p53) and p21 (a direct target of p53), we tested whether activation of p53 pathway contributes to the developmental defects of mats1 morphants. To do this, we co-injected p53 MO with mats1 MO2 and confirmed that p53 MO can effectively reduce p21 and ∆113p53 (p53 MO binds to p53 start codon, so it can block p53 translation without affecting RNA expression of p53) expression. However, mats1/p53 morphant embryos still exhibited the developmental delay phenotype (Supplementary Figure  S3A) . These results further support that reduction of mats1 function disrupted normal embryogenesis.
Reduction of mats1 expression and function causes developmental delay. At 24 hpf, delayed mats1 morphants only had 14-22 somites just like 16-20 hpf wild-type embryos, whereas wild-type siblings had 26 somites. More than 50% of mats1 morphant embryos that showed severe developmental delay phenotype only had less than 16 somites. The trunk of mats1 morphants was shorter and more curved (Figure 3 , A-C). Given more time, mats1 morphants developed more somites although their overall morphology was still abnormal. Development of the central nervous system was also delayed (Figure 3 , A'-C' and A''-C''). Consistently, the head and eyes of mats1 morphants usually were smaller. Assessment of marker genes like no tail, goosecoid, frb35, pax2, myoD showed that expression of these genes was delayed without changing their expression patterns (data not shown). The delayed phenotype was also found in mats1 morphant embryos
of mats1 function. To test this idea, we first determined whether cell proliferation in mats1 morphant embryos was defective. For this purpose, we used BrdU staining to mark S-phase cells and phosphohistone H3 (PH3) antibody staining to mark M-phase cells. At 24 hpf, BrdU incorporation decreased in mats1 morphant embryos (36/41) compared to wild-type siblings and siblings injected with MO Ctl (Figure 4 , A-F). This reduction of S-phase cells was more evident in mats1 morphant embryos showing severely delayed phenotype than normal-looking morphant embryos. The same experiment was repeated with 10 hpf embryos, and the results were consistent with those of 24 hpf embryos (Figure 4 , G-K). Since mats1 morphant embryos were developmentally delayed, the decrease of S-phase cell number could be attributed to age differences between mats1 morphant and control embryos. To test this, mats1 morphant embryos were cultured for a few more hours until they reached the tail bud stage (equivalent to10 hpf in wild-type embryos at 28.5°C). Embryos that showed severe developmental delay needed 13 h to reach this stage, while those that showed a mild phenotype needed 11-12 h. Interestingly, these embryos still did not have the same number of S-phase cells as control embryos at 10 hpf ( Figure 4 , compare H-I with G). PH3 antibody staining was done to identify mitotic cells in embryos. At an early stage (10-13 hpf), the number of mitotic cells in severely delayed mats1 morphant embryos was decreased compared with uninjected siblings and embryos injected with MO control (about 50% of control embryos) (Figure 4, N-O) . But at 24 hpf, the PH3 staining results didn't show marked difference when comparing mats1 morphants with control embryos. The difference between BrdU and PH3 staining suggests that mats1 may be involved in cell cycle control. To further test this idea, fluorescence-activated cell sorting (FACS) analysis was done with mats1 morphant and control embryos at 24 hpf to see whether the ratios of cells at different phases of the cell cycle changed. We at earlier stages. At 10 hpf, epiboly of siblings injected with MO Ctl was already complete but mats1 morphants showed only 50-90% epiboly ( Figure 4K ). At about 3 hpf, when wild-type siblings reached the 1000 cell stage, the cleaving morphant embryos had fewer but larger cells, demonstrating that they divided less often than their wild-type siblings (Figure 3 , compare F-F' with D-D' and E-E'). Thus, reduction of mats1 function impedes embryonic development.
Knockdown of mats1 function also reduced viability of the morphants. About 50-80% mats1 morphants showing abnormalities survived five days post fertilization (dpf), while others died along the way. When wild-type embryos normally hatched from 48 hpf to 72 hpf, the mats1 morphants did not hatch from the chorion, and consequently, only survived up to 5 dpf before using up the yolk. Those that successfully hatched were unable to escape and swim away when touched. Instead, they could only circle at the same location, likely due to defects in their neural and muscular systems. Moreover, some mats1 morphants also exhibited defects such as pericardial expansion, reduced number of otoliths, and decreased density of blood cells. Thus, mats1 function appears to be required throughout development in many tissues.
Defective cell proliferation in mats1 morphant embryos
Our analysis has focused on growth defects of mats1 morphant embryos. Because mats1 morphants had fewer cells than wild-type siblings at the same age, cell proliferation and/or apoptosis were likely aberrant due to the reduction
found that the ratio of cells at the M-phase in mats1 morphant embryos was more than that of the control embryos (13.33+0.57* vs. 9.60+0.20*, "*" represents standard error, t-test, p<0.005), while the ratio at S-phase didn't change much in mats1 mrophant embryos compared to control embryos (29.68±1.00* vs. 30.82 ± 0.74*, "*" represents standard error). These results indicate that loss of mats1 function may have mitotic defects that cause the accumulation of mitotic cells.
Apoptosis increased in mats1 morphant embryos
To test whether mats1 is involved in regulating cell death, the TUNEL assay was done at 24 hpf, when apoptosis normally occurs in developing embryos. Compared to control embryos ( Figure 5 , A and C), mats1 morphant embryos showed an increase in TUNEL-positive cells (29/38) ( Figure 5, B and D) . Thus, more cells died in mats1 morphant embryos. The results are similar when coinjected with p53 MO. Thirty-nine out of 46 mats1/ p53 morphant embryos still exhibited excessive apoptosis with decreased signal in head region ( Figure S3B ), which are consistent with a former report (Robu et al., 2007) .
To determine whether cell death in mats1 morphant embryos is mediated through apoptosis, cleaved Caspase 3 antibody staining was done to specifically label apoptotic cells. The results of cleaved Caspase3 staining were consistent with the TUNEL results ( Figure 5 , E-H). Compared to control embryos (Figure 5 , E and G), mats1 morphant embryos clearly exhibited increased apoptosis at 24 hpf (50/50), mainly in the head and caudal parts ( Figure 5, F and H) . Thus, knockdown of mats1 leads to increased cell death, and this occurs mainly through apoptosis.
mats1 morphant cells have a growth advantage in chimeric zebrafish embryos
Loss of mats function causes mutant cells to overproliferate in mosaic fruit flies (Lai et al., 2005) . To determine how mats1-deficient cells might behave when surrounded by normal cells in zebrafish, we carried out cell transplantation experiments to generate mats1 chimeric embryos (Supplementary Figure S4) . From three independent experiments, four hundred thirty one mats1 morphant cells and 522 cells from embryos injected with MO Ctl were transplanted into more than 130 embryos at the 3-4 hpf stage. By 10 hpf, they had proliferated to generate 3,010 and 2,840 cells, respectively. Therefore, their respective proliferation index (PI) was 6.98 and 5.44 (t-test, p <0.0001; Table 1 ). From two other control experiments, the proliferation index of cells from embryos injected with FITC or Rhodamine were 5.84 and 5.59 respectively, similar to cells from embryos injected with MO Ctl (Table 1) . Similar to control normal cells, mats1 morphant cells distributed throughout the embryo. These results suggested that mats1 morphant cells in chimeric embryos had a growth advantage and proliferated more than normal cells. Thus, the growth inhibitory activity of mats family genes appears to be conserved in zebrafish.
Discussion
All vertebrate Mats proteins share extremely high levels of sequence identity with Drosophila Mats. Yet functional significance of mats genes in vertebrate development has not been investigated. On the basis of functional analysis of mats in Drosophila (Lai et al., 2005; Wei et al., 2007; Shimizu et al., 2008) , we hypothesized that zebrafish mats1 plays a critical role during embryogenesis. Supporting this idea, mats1 is expressed in developing embryos. Using a morpholino-based loss-of-function analysis, we found that mats1 plays a critical role in regulating cell proliferation and apoptosis in early embryos. Similar to Drosophila homozygous mats mutants (He et al., 2005; Shimizu et al., 2008) , reduction of mats1 expression caused severe develop- 
MATS1 MORPHANT CELLS PROLIFERATE FASTER THAN WILD-TYPE CELLS IN CHIMERIC EMBRYOS
Proliferation index (PI, defined by N2/N1) of four types of cells. N1 refers to the cell number at 3-4 hpf, and N2 refers to the cell number at 10 hpf. mats1 MO2:mats1 MO2 morphant cells. MO Ctl: cells from embryos injected with control MO. FITC Ctl: cells from embryos which were only injected with FITC. Rhodamine Ctl: cells from embryos which were only injected with Rhodamine. "*" represents standard error. It is calculated with average proliferation index derived from three independent transplantation experiments, and represents the deviation of PI on average. Growth inhibitory role of mats appears to be conserved in zebrafish mats was first discovered in Drosophila as a tumor suppressor because loss of mats function caused tissue overgrowth in mosaic flies (Lai et al., 2005) . In this study we have tested whether the growth inhibitory activity of mats family gene is conserved in vertebrates by generating chimeric zebrafish embryos through cell transplantation. Interestingly, chimeric analysis showed that mats1 morphant cells proliferated faster than control normal cells, just like mats mutant cells in mosaic fly tissues. It is less likely that the increase of mats1 morphant cell number was caused by inhibition of cell death, since cell death barely occurs before 10 hpf. Thus, this growth-inhibitory role of mats appears to be evolutionarily conserved between invertebrates and vertebrates. mats1 morphant cells in chimeric embryos had a growth advantage likely through competition with neighboring wild-type cells. To acquire such a growth advantage, mats1 morphant cells may need to be stimulated by surrounding wild-type cells, or capable of inhibiting growth of neighboring wild-type tissues. Although the mechanism by which mats1 morphant cells acquire growth advantage in the context of chimeric embryos is presently unknown, cell-cell interaction should play a critical role in this process. A future challenge is to reveal the molecular basis of this intercellular interaction critical for tissue growth control during animal development.
Materials and Methods
Animals
The wild-type Tübingen strain or Tübingen/AB stain zebrafish and a transgenic line 1040 whose central nervous system is marked by GFP were used in this study. Zebrafish embryos were obtained by natural spawning, raised at 28.5 °C (±0.5 °C) in Holtfreter's solution and the developmental stage determined as described by KIMMEL et al. (1995) .
Whole-mount in situ hybridization
Digoxigenin-labeled antisense RNA probes were generated in vitro by using a zebrafish mats1 full-length cDNA as template with T7 or SP6 RNA polymerase (Promega, Madison, WI). Whole-mount RNA in situ hybridizations were performed essentially as described in The Zebrafish Book (Westerfield et al., 1995) on embryos at the following developmental stages: 1 cell, 3 hours after fertilization (hpf), 6 hpf, 8 hpf, 10 hpf, 19 hpf, 24 hpf, 30 hpf, 36 hpf, 48 hpf and 72 hpf.
In vitro mRNA synthesis
Capped mRNAs were transcribed from linearized DNA using T7, T3 and SP6 RNA polymerase in vitro transcription kits according to the manufacturer's instruction (mMESSAGE, mMACHINE; Ambion). The pCMV-SPORT6 and pXT7 vectors were used. Moreover, site-directed mutagenesis through fusion PCR was done to make five silent nucleotide replacements within the MO2-binding site of mats1 to convert 5'-CCATTTGATTTCAGC GGA AAC CGT T-3' to 5'-CCATTTGATTTCAGt GGg AAt aGg T -3'. This mutant mats1 still encodes a wild-type Mats protein product and its mRNA was synthesized in vitro as described above for the rescue experiment.
Microinjection
Capped mRNAs and morpholinos were dissolved and diluted in nuclease-free water to an appropriate concentration. They were injected into 1-to 2-cell-stage embryos in yolk. The amount of injection was determined by measuring the volume of liquid injected into a 1-µl capillary glass (34 mm long) using a ruler, and volume per microinjection was thereby calculated.
Morpholino design and phenotypic analysis
One translation-blocking morpholino (MO1) and one splice-blocking morpholino (MO2) of mats1 were synthesized by Open Biosystems, Inc. (Huntsville, AL). The sequence of MO1 is: 5'-TTCCGAATAAGAAACTCATCTCCGC-3', which corresponds to the start codon region, and the sequence of MO2 is: 5'-AACGGTTTCCGCTGAAATCAAATGG-3', which corresponds to the putative intron1-exon2 boundary of mats1.
A translation blocking morpholino targeting p53 from Gene Tools (Philomathe, OR) was used to eliminate p53 dependent off-target effect, its sequence is 5'-GCGCCATTGCTTTGCAAGAATTG-3'. A standard control morpholino oligo (MO Ctl) from Gene Tools (Philomathe, OR) was used as control. Its sequence is 5'-CCTCTTACCTCAGTTACAATTTATA-3'.
Injected embryos were cultured in Holtfreter's solution at 28.5 °C (±0.5 °C). An embryo was considered abnormal if it showed less than 90% epiboly when its siblings injected with the same mount of MO Ctl exhibited complete epiboly at the 10 hpf stage, or if it appeared younger than 20 hpf (defined by its overall look and somite number) compared to its siblings injected with the same mount of MO Ctl at the 24 hpf stage.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and quantification
For detection of expression pattern of mats1 during early development, total RNA was extracted from wild-type embryos at various stages with Trizol reagent (Invitrogen, Carlsbad, CA). To detect splice-blocking variants of mats1 mRNA with RT-PCR, total RNA was extracted from the morphant and control embryos (injected with MO Ctl at the same quantity and uninjected wild-type siblings) at 10 hpf and 24 hpf. Reverse transcription was carried out with random nonamer by using M-MLV reverse transcriptase (Promega, Madison, WI) 
BrdU staining
BrdU (5-bromo-2-deoxyuridine) (Roche Diagnostics, Mannheim, Germany) staining was performed to label S-phase cells. It was done essentially according to the protocol in Methods in Cell Biology (Detrich et al., 2004) . Embryos were dechorionated and chilled 15 minutes on ice in Holtfreter's solution, then placed in cold 10 mM BrdU/15% Dimethylsulfoxide (DMSO) in Holtfreter's solution and chilled on ice for 20 minutes to allow uptake of BrdU. Then embryos were changed into warm Holtfreter's solution and incubated exactly 5 minutes at 28.5 °C. They were fixed 2 hours at room temperature in PFA (4% paraformaldehyde buffered with 1 x PBS), dehydrated in graded methanol:PBS series (1:3,1:1, 3:1) and preserved in methanol at -20 °C at least overnight. Rehydrated in graded methanol:PBST [1xPBS with 0.1% (v/v) Tween-20] series (3:1,1:1,1:3) for 5 minutes each, followed by in PBST twice, 5 minutes each. Embryos were digested in 10 µg/ml proteinase K for 10 minutes, washed in PBST for 5 minutes, and refixed in PFA for no more than 20 minutes, followed by 3 times quick washes in H 2 O with 0.1% (v/v) Tween-20 and 2 times in 2N HCl. Embryos were incubated 1 hour in 2N HCl to denature the labeled DNA to expose the BrdU epitope, rinsed several times in PBST to bring the pH back up to approximately 7 before adding blocking solution, and then blocked for at least 30 minutes in blocking solution (1% DMSO + 0.1% Tween-20 + 1% BSA + 2% serum in PBS). After that, embryos were incubated in monoclonal anti-BrdU antibody (Zhong Shan Jin Qiao) at a dilution of 1:100 in blocking solution overnight at 4 °C. Subsequently, embryos were washed in PBST five times, 10 minutes each, and incubated in horseradish peroxidase-conjugated anti-mouse secondary antibody about 2 hours at room temperature. Finally, embryos were washed in PBST five times, 10 minutes each. Color reaction was developed with diaminobenzidine.
PH3 and cleaved Caspase 3 antibody staining
Mitotic cells were stained with a rat polyclonal anti phosphorylated histone H3 antibody from Upstate Biotechnology (Charlottesville, VA). It was performed essentially as described in The Zebrafish Book (Westerfield et al., 1995) , with a dilution of 1:1000, and the horseradish peroxidasecoupled secondary antibody was diluted 1:250. Cleaved caspase3 antibody staining was performed to detect apoptotic cells. The method is basically the same with PH3 staining, and the cleaved Caspase-3 (Asp175) antibody from Cell Signaling Technology, Inc. (Beverly, MA) was diluted 1:100 and the horseradish peroxidase-coupled secondary antibody was diluted 1:250.
TUNEL staining
For detection of cell death, terminal desoxynucleotidyl transferase mediated biotinylated UTP nick end labeling (TUNEL) was performed, using the In situ Cell Death Detection Kit (Roche Diagnostics, Mannheim, Germany). Embryos were dechorionated and fixed overnight at 4 °C in PFA, dehydrated in a graded ethanol:PBS series (1:3,1:1,3:1), then preserved in ethanol at -20 °C for at least 30 minutes. Embryos were rehydrated in a graded ethanol:PBST series (3:1,1:1,1:3) for 5 minutes each, washed in PBST for 5 minutes, then digested in proteinase K (10 µg/ml) at room temperature for 10 minutes. After being washed twice in PBST, embryos were postfixed in PFA for 20 minutes at room temperature. With 5 times washes in PBST, 5 minutes each, embryos were postfixed for 10 minutes at -20 °C with pre chilled ethanol:acetic acid (2:1). After being washed in PBST three times, 5 minutes each at room temperature, embryos were used for TUNEL assay according to manufacture's instruction.
Cell transplantation
Eggs were collected and raised in Holtfreter's solution with 50 units penicillin and 50 µg streptomycin per ml (Gibco). Eggs that were used as donors were microinjected with Fluorescein isothiocyanate-dextran (FTIC) (Sigma Chemical Co., St. Louis, MO) or tetramethylrhodamine-dextran (TMR) (Invitrogen) (5% in nuclease-free water) or one combination of mats1 MO2 or MO Ctl with one of these two dyes. Cell transplantation began at the 1000-2000 cells stage. Since mats1 MO2 could cause developmental delay started before the 1000 cell stage, embryos injected with mats1 MO2 were raised at 28.5 °C (±0.5 °C) while the sibling embryos injected with MO Ctl and embryos without injection were raised at 25.5 °C (±0.5 °C) to adjust their development stage. The temperature was calculated using the formula described in (Kimmel et al., 1995) . To maximally eliminate the difference of proliferation ability among cells from different location, all the transplanted cells were fetched in the center of the deep layers of injected embryos. One to five transplanted cells from each donor embryos were loaded by suction, and then were injected among the deep cells at the center of the same wild-type sibling at the same stage, without damaging the yolk cell. The numbers of each marked cells were counted (record as N1) under fluorescent microscope after cell transplantation was done (usually about 1 hour from the first transplant was done) one by one in the order of transplantation, and counted again at about 10 hpf (record as N2). N2 divided with N1 is the index of cell proliferation ability.
Imaging
Images of zebrafish embryos were acquired by using an Imager Z1 or Stemi 2000-C microscope equipped with an AxioCam digital camera and AxioVission software (Zeiss, Oberkochen, Germany), and then edited with PhotoShop CS2 9.0 (Adobe Systems, San Jose, CA).
